soc-neuro-onc.org
Financial Highlights Fiscal Year Ended June 30, 2022
The following financial highlights are prepared by management of the Society for NeuroOncology for the fiscal year ended June 30, 2022 and are intended for this Annual Report, only. The financial information is in the process of being audited by an independent accounting firm. Once the audit is complete, the financial statements and Independent Auditor’s Report will be posted at www.soc-neuro-onc.org.
Statement of Financial Position highlights, as of June 30, 2022:
Cash and cash equivalents
$ 2,091,000
Investments
$ 3,121,000
Contributions receivable
$ 895,000
Endowment assets
$ 317,000
Total assets
$ 6,424,000
Liabilities
$ 305,000
Net assets
$ 6,119,000
Total liabilities & net assets
$ 6,424,000
Statement of Activities highlights, for the fiscal year ended June 30, 2022:
T otal revenues and other support
$ 3,869,000
Total program and supporting service expenses
$ 4,359,000
Change in net assets
$ (490,000)
Society for Neuro-Oncology 13
Made with FlippingBook - Share PDF online